Compare ANIX & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANIX | PED |
|---|---|---|
| Founded | 1982 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.0M | 152.8M |
| IPO Year | 2013 | 2012 |
| Metric | ANIX | PED |
|---|---|---|
| Price | $2.73 | $12.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $8.67 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 346.6K | 28.4K |
| Earning Date | 05-27-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.82 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $210,000.00 | ★ $45,751,000.00 |
| Revenue This Year | N/A | $171.75 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.67 |
| 52 Week Low | $2.32 | $0.43 |
| 52 Week High | $5.46 | $18.89 |
| Indicator | ANIX | PED |
|---|---|---|
| Relative Strength Index (RSI) | 34.58 | 43.06 |
| Support Level | $2.37 | $11.41 |
| Resistance Level | $3.09 | $13.92 |
| Average True Range (ATR) | 0.17 | 1.16 |
| MACD | -0.03 | -0.23 |
| Stochastic Oscillator | 17.74 | 4.79 |
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties with a long production history, well-defined geology, and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming, the Powder River Basin (PRB) in Wyoming, and the San Andres formation of the Permian Basin situated in West Texas and eastern New Mexico (the Permian Basin).